Sort by relevance
Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical needs. Our ambition is to be the world’s leading and most valued generics company. Our broad portfolio of high-quality medicines, covering major therapeutic areas, accounted for 2021 sales of USD 9.6 billion.
Sandoz supports diversity, equal opportunity and inclusion. Sandoz is committed to building diverse teams, reflecting the interests of its patients and external stakeholders. Sandoz strives to create an inclusive working environment that facilitates collaboration, encourages breakthrough innovations and gives its employees the means to achieve their full potential.
Copyright Sandoz December 2022